§ EQUITY
USDENTX
ENTERA BIO LTD
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Knoll Capital Management, LLC | 5.9M | 3.6% | ±0% |
| Renaissance Technologies | 473K | 0.0% | +338% |
| Parkman Healthcare Partners LLC | 289K | 0.0% | +5% |
| Citadel Advisors | 246K | 0.0% | +510% |
| Marshall Wace LLP | 193K | 0.0% | −69% |
| Northern Trust Corp | 147K | 0.0% | −1% |
◇ AC INTELLIGENCE
Top institutional owners for ENTX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER85.8% · 15 holders
SYSTEMATIC / QUANT8.5% · 3 holders
TACTICAL / MACRO3.1% · 1 holder
DEALER / BANK2.3% · 6 holders
PASSIVE / INDEX0.3% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ENTX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ENTX yet.